Summary. This is a report of development of (1) a 3-day immature mouse bioassay for alpha-fetoprotein (AFP) to increase the working range in uterine wet weights overcoming seasonality, and (2) a bioassay for AFP performed with ovariectomized adult mice to increase sensitivity. Mouse AFP was isolated from amniotic fluid and purified by polyacrylamide gel electrophoresis followed by Blue Sepharose chromatography. The uterine growth evoked by the injection of 1\m=.\0 \ g=m\ g AFP together with excess molar oestradiol (0\m=.\5\g=m\g) over a 23-h period was compared in immature ovariectomized adult Nylar mice. The 3-day assay with immature mice was rendered usable in any season, with sensitivity comparable to the 1-day assay. Increased sensitivity, however, was demonstrated by utilization of AFP in a 1-day assay with the adult ovariectomized mouse.
Introduction
Alpha-fetoprotein (AFP) is a glycoprotein of Mr 70 000 first discovered in human fetal blood by Bergstrand & Czar (1957) . It was later found in the blood of hepatoma-bearing mice by Abelev et ai (1963) and in tumour-bearing human patients by Tatarinov (1964) . Further research indicated that certain AFPs could bind oestrogen as well as other ligands (Aoyagi et al, 1918; Savu et al, 1981) . It was subsequently reported that AFP displayed growth-regulatory properties (Abelev, 1971; Soubiran et al, 1979; Toder et al, 1983; Mizejewski & Jacobson, 1987) . Clinically, the presence of this tumour-associated fetal protein has been exploited for screening purposes (Kithier et al, 1966; Brock & Sutcliffe, 1972; Leek et al, 1973) but its growth-regulatory potential has remained largely untapped.
AFP inhibits the oestrogen-stimulated uterine growth response in immature mice when the AFP is incubated with excessive amounts of oestradiol for 1 h before injection (Mizejewski et al, 1983 (Mizejewski et al, , 1986 ). This inhibitory effect of oestradiol-activated AFP cannot be explained simply by the ability of this molecule to bind to and sequester oestrogen (Raynaud, 1973) , since a significant inhibitory effect was seen when the molar amount of AFP in the reaction mixture was less than 1% ofthe molar amount of oestradiol employed, and subsequent additional injections of oestradiol in an amount well in excess of that which AFP could sequester could not overcome the inhibition (Mizejewski et al, 1983 ). The effect is protein specific for AFP being non-reactive with albumin and transferrin and steroid-specific for oestradiol and oestrone but not moxoestrol. Therefore, we proposed that the antiuterotrophic action of AFP represents a growth regulatory property of the molecule.
Purified mouse AFP preparations that are stored for prolonged periods progressively lose their growth-inhibiting activity and ultimately acquire a growth-potentiating activity: both biological activities co-existed in fresh amniotic fluid and resided in different fractions which could be separ¬ ated by oestradiol-affinity chromatography (Mizejewski & Jacobson, 1987) . The decayed inhibitory activity of AFP can also be regenerated in aged AFP preparations by treatment with high salt (0-4 M-KC1). It would therefore appear that AFP has molecular variants which, depending on their relative abundance in the preparation, constitute a mixture in mouse amniotic fluid which is capable of (a) growth inhibition, (b) no effect on cell growth, or (c) growth enhancement. To study further these varied activities, we needed to discriminate better smaller differences in uterine wet weight and increase the sensitivity of our AFP bioassay system (Mizejewski et al, 1986) .
In the present report, we describe our development of (1) (Mizejewski et ai, 1983 (Mizejewski et ai, , 1986 ).
Biochemical and immunochemical methods. Protein in amniotic fluid and in AFP isolates was determined by the method of Lowry et al. (1951) . AFP concentrations were determined using the radial immunodiffusion procedure (Mancini et ai, 1965) and by rocket electrophoresis (Laurell, 1966) with a purified AFP standard of hepatoma origin (Allen & Mizejewski, 1977) . Rocket electrophoresis was also used to quantitate AFP in sera obtained from immature mice. Purity of AFP preparations was ascertained by immunoelectrophoresis (Scheidigger, 1955) and by immunodiffusion (Ouchterlony, 1968) AFP from mouse amniotic fluid was purified by preparative polyacrylamide gel electrophoresis (PAGE), using discontinuous gradient polyacrylamide gels (Joshi & Ebert, 1976) . The lyophilized product was reconstituted and dialysed against phosphate-buffered saline (PBS), pH 7-2. This preparation was freed of residual albumin by affinity chromatography on Blue Sepharose (Kelleher et ai, 1979) . Quantitation of AFP in each purified protein preparation was performed both by analysis for total protein and for immunoreactive AFP by rocket electrophoresis.
All AFP preparations fulfilled the criteria of purity that were previously described (Mizejewski et ai, 1979a, b) . These include: presence of a single band after polyacrylamide gel electrophoresis, a single line of precipitation with an antiserum against mouse amniotic fluid which normally produces 3-4 precipitin lines when challenged with amniotic fluid, a single precipitin arc in the alpha-1 position after immunoelectrophoresis with anti-mouse amniotic fluid, failure to produce a precipitin line against rabbit antisera to adult mouse serum proteins, and production of monospecific antibodies against mouse AFP when used to immunize guinea-pigs and/or rabbits.
Other materials from mouse amniotic fluid that were examined were amniotic fluid incubated for 15 min at 4°C with a suspension of dextran-coated Norit charcoal (Sigma, St Louis, MO, USA) (Mizejewski et ai, 1980) , followed by centrifugation for 10 min at 3000 g. This treatment has been reported to convert inactive AFP to an active form (Mizejewski et ai, 1983) .
Antiserum production and its specificity. The production of rabbit antiserum to AFP purified from mouse amniotic fluid has been described (Mizejewski & Allen, 1978) . Immunoelectrophoresis of mouse amniotic fluid against this antiserum produced a single precipitation arc in the alpha-1 region. By immunodiffusion it formed a single band of identity against mouse amniotic fluid, which was continuous with a band formed against purified AFP of hepatoma origin (Allen & Mizejewski, 1977) . Finally, the antiserum produced a single peak when subjected to rocket electroimmunodiffusion against mouse amniotic fluid in purified and crude preparations.
Oestrogen response in the uterus ofthe immature mouse. Stock solutions of oestradiol-17ß in 95% ethanol (100 pg/ ml) were diluted with phosphate-buffered saline (pH 7-2) to produce injectants containing 0-5 pg oestradiol in 100 pi solution. With a tuberculin syringe equipped with a 26-gauge needle, immature female mice were injected intra¬ peritoneally (i.p.) with µ of this oestradiol solution and/or protein mixtures and were returned to their original cage. The transient increase in uterine weight that this treatment evokes is maximal 20-24 h after the injection and is the result of cell proliferation as determined by mitotic indices (Mizejewski et al, 1983) . For convenience, a standard 23-h interval was adopted. After that time, the mice were weighed, decapitated and bled. The uteri were exposed by a midventral incision and the ovary and oviduct were dissected away from the anterior portion of each of the uterine horns. A posterior cut at the corpus uteri was used to free the organ from the vaginal chamber. The uteri were trimmed free of mesenteries and immediately weighed. The ratio of uterine to body weight was calculated to normalize differences in body weight among litters of the same age.
We also examined the AFP response to the uterine growth in Nylar young given a single injection of oestradiol-17ß and oestradiol-17ß + AFP on j, 2 or 3 days in succession. Mice were then killed on the day after the last injection.
Oestrogen response in the uterus ofovariectomized adult mice. Adult virgin female Nylar mice were ovariectomized under anaesthesia with 0-3 ml pentobarbitone sodium (50 mg/ml diluted 1:10 with PBS, pH 7-2) and were randomly assigned to treatment groups. Oestradiol-17ß (005-2-5 pg) in 100 µ volumes containing 5% ethanol was given i.p. at 10 days after ovariectomy. Other groups were non-injected littermates. PBS-ethanol controls were similar to the untreated controls as found in immature mice (Mizejewski et ai, 1983) . Uterine weights were determined at autopsy 23 h after injection. In one experiment, purified mouse AFP in doses of 0T, 10, 50, 10, 20 and 40 pg per mouse was titrated with 0-5 pg oestradiol-17ß for testing in the adult ovariectomized mouse.
'Bioassay'for inhibition or enhancement by AFP of oestrogen-induced uterine growth. Kinetic studies have shown that the binding of oestradiol to AFP preparations is a complex process which is complete after 1 h of incubation (Mizejewski et ai, 1982) . Therefore, the oestradiol injectant solution was incubated at 25°C with various amounts of amniotic fluid or purified AFP preparations 1 h before its administration to the mice. Each 100 pi PBS for injection contained 0-5 pg oestradiol and different amounts of the AFP solution under test, usually 1 0 pg. At 23 h after injec¬ tion, the immature and/or ovariectomized adult mice were autopsied and uterine weights determined as described above. The effect of the protein is expressed as the change that its inclusion in the injectant has imposed on the oestrogen-stimulated gain in uterine weight, expressed as a percentage of oestradiol-stimulated weight gain: inhibition = 100 (E-EP)/(E-C) in which E and EP are the mean uterine weight mg/g body weight in the groups given oestradiol and oestradiol + AFP respectively, and C is the mean for untreated controls. Unless otherwise stated, all single-day bioassays used 10 pg purified mouse AFP together with 0-5 pg oestradiol-17ß per injection.
Storage procedures ('aged' AFP). Purified AFP preparations were routinely dispensed into 50 pi amounts and stored frozen ( -20°C) . Both storage at -20°C for 4 weeks or longer or 3 freeze/thaw cycles are known to produce aged AFP preparations as previously described (Mizejewski & Jacobson, 1987 
Results
Bioassay of 3 daysfor AFP regulation of oestradiol-induced uterine growth During the 'low sensitivity' season we examined uterine growth in groups of young given 1, 2 or 3 daily injections of oestradiol or oestradiol + AFP (Table 1 ). The degree of inhibition after 3 days of treatment was sufficient to prepare a dose-response standard curve of antiuterotrophic activity (Fig. la) .
A dose-response curve for the uterine growth-potentiating activity of aged AFP was also generated following 3 days of treatment (Fig. lb) . The maximum inhibition as well as maximum enhancement activity occurred at the same daily dose of AFP (10 pg daily).
Oestrogen-induced uterine growth in the ovariectomized mouse As shown in Fig. 2 , the largest oestrogen dose, 2-5 pg/mouse, produced a uterine wet weight 4 times that found in untreated ovariectomized controls and comparable to that found in cycling intact females (see Table 3 ). Bioassay for AFP activity performed in adult ovariectomized mice As displayed in Table 2 , doses of 01, 1-0 and 50 pg AFP each inhibited by at least one-third (P < 0-005 to 0-05) the uterine growth induced by 0-5 pg oestradiol-17ß, whereas doses of 10, 20 and 40pg AFP/mouse were without significant effect (P > 005). In the adult ovariectomized mouse, therefore, the co-administration of 1/1300 mole fraction of AFP with 0-5 pg oestradiol effects inhibition of the uterotrophic response to the oestrogen, while in the immature mouse 10 times more AFP is required for nearly similar results ( Table 2 ). The largest inhibition observed (82%) was imposed by 50 pg AFP on the much larger uterine growth that was elicited by 2-5 pg oestradiol (Table 3 ). In contrast, AFP that is contained in mouse amniotic fluid had no activity, while charcoal treatment of this amniotic fluid generated some growth-inhibitory effect (Table 4) . These results were comparable to those of studies with immature mice with 57% inhibition in the former and 45 % in the latter (Table 4) .
Purified mouse AFP preparations that had been stored at -20°C for 12 weeks produced a 12% potentiating effect (P < 005) in the ovariectomized adult mouse, comparable to a 10% potentiating effect in the immature mouse (Table 5) . Table 2 since the animals were done during the same time period. (Boyd & Spelsberg, 1979) . The oestrogen response in the uterus of immature mice (0-5 pg/mouse) tracked monthly for 2 consecutive years, in our laboratory, also displayed seasonality (Jacobson & Mizejewski, 1985) . Depending on the season, a quantitative bioassay of antiuterotrophic or potentiating activity would require a broader dose-response curve than the 23-h assay with a single AFP dose provides. We have therefore extended the working range of the uterine wet weights of our bioassay by development of a 3-day assay. To achieve an adequate working range in uterine wet weights in which several points can be adequately discrimi¬ nated, a dose-response curve for inhibition of oestradiol-induced uterine growth at any season requires that the uninhibited uterine growth must exceed 5 0 mg. Further, this must be obtainable in the season of low uterine responsiveness if the procedure is to have year-around utility. This has been achieved by utilization ofthe 3-day bioassay procedure (Table 1 ; Fig. 1 ) in which 3 daily doses of AFP plus oestradiol-17ß are administered to immature female mice. This AFP assay is similar to the standard 3-day mouse bioassay for steroids (Hilgar & Palmore, 1965) . Although the assay was rendered usable in any season, its sensitivity (i.e. minimum dose of AFP) was not measurably improved over the 1-day assay.
Increased sensitivity was, however, achieved by performance of the single-dose 23-h AFP bioassay in the adult ovariectomized mouse. In such animals, at 10 days after ovariectomy, 0-5 pg oestradiol-17ß generated a mean uterine growth of 110 mg/g body weight or 30 mg uterine wet weight per mouse (Table 3 ). The greatest inhibition of 0-5 pg oestradiol-induced uterine growth (35% or about 10 mg wet weight) was obtained with a 10 pg dose of AFP. The range of 0 to 10 mg wet uterine weight was found to be adequate for generation of a growth-inhibition standard curve. Inhibition of uterine growth in ovariectomized mice was also produced by 0-1 pg AFP, which was only 10% ofthe dose required to produce such inhibition in the immature mouse. However, 50 pg AFP together with 2-5 pg oestradiol imposes an impressive 82% inhibition on uterine growth (Table 3) . Comparable results were also produced for potentiation of uterine growth by 'aged' AFP (Table 5) when the ovariectomized mouse assay was compared to that of the immature mouse uterus assay. The adult ovariectomized mouse, with greater sensitivity and range of oestradiolstimulated uterine growth (wet weight) and low circulating AFP, appears to be suitable for study of the growth-inhibitory and -enhancing properties of mouse AFP. Although a dose-response for the uterine growth-inhibitory property of mouse AFP has already been described (Mizejewski et al, 1986) , the present results represent the first report of a dose-response for the growth-potentiating (enhancing) activity of AFP. The dual activities of AFP preparations regarding uterine growth regulation display comparable yet contrasting dose responsiveness. Both assay graphs (Fig. 1) 
